Syndivia is a laureate AstraZeneca's open innovation program - ReAliZe

Written By Syndivia

STRASBOURG (France) – October 2, 2019 – Syndivia is nominated laureate of ReAliZe in the Scientific Innovation category. ReAliZe is an open innovation program of AstraZeneca supporting oncology start-ups and focusing on 4 main areas: data management, scientific innovation, patient care and artificial intelligence.

Syndivia https://syndivia.com
Previous

Syndivia Raises €1M Investment to Advance Its Tumour Microenvironment Drug Delivery Platform

Next

Syndivia and BFCL publish review of Antibody–Oligonucleotide Conjugates (AOC) as therapeutic, imaging, and detection agents